Pharmaceutical preparation for treating blood coagulation disord

Details Pharmaceutical preparation for treating blood coagulation disord Pharmaceutical preparation for treating blood coagulation disord

1997-03-20

1999-02-02

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

514 2, 604187, A61K 3848, A61K 3800

Patent

active

058661220

ABSTRACT:
There is disclosed a pharmaceutical preparation for treating blood coagulation disorders which comprises purified prothrombinase factors, in particular purified prothrombin and optionally purified factor Xa as active component.

REFERENCES:
patent: 4287180 (1981-09-01), Thomas
patent: 4501731 (1985-02-01), Tishkoff et al.
patent: 4721618 (1988-01-01), Giles et al.
patent: 5120537 (1992-06-01), Esmon et al.
patent: 5585259 (1996-12-01), Lauwreys et al.
patent: 5593968 (1997-01-01), Turecek et al.
patent: 5618788 (1997-04-01), Copon et al.
patent: 5698677 (1997-12-01), Eibl et al.
The Merck Index, Windholz et al 10th Ed. pp. 566-567, abstract no. 3862-3869, 1983.
Vlasuk et al., "Comparison of the In Vitro Anticoagulant Properties of Standard Herparin and the Highly Selective Factor Xa Inhibitors Antistasin and Tick Anticoagulant Peptide (TAP) in a Rabbit Model of Venus Thrombosis", vol. 65, No. 3, 257-262 (1991).
Drouet et al., "The Effect of Recombinant Human Von Willebrand Factor in Pigs with severe Von Willebrand's Disease", Blood, vol. 86, No. 10, 612a-Abs.No. 2435 (1995).
Raymond et al., "Characterization of the Fawn-Hooded Rat as a Model for Hemostatic Studies", Thrombos. Diathes, haemorrh., vol. 33, 361-369 (1975).
Tschopp et al., "Hereditary Defect in Platelet Function in Rats", Blood, vol. 40, No. 2, 217-226 (1972).
Giles et al., "A Canine Model of Hemophillic (Factor VIII:C Deficiency) Bleeding", Blood, vol. 60, No. 3, 727-730 (1982).
Brummelius, "Preparation of the Prothrombin Complex", Methods of Plasma Protein Fractionation, Curling, J.H. ed., 117-128, Acedemic Press, New York (1980).
Fareed et al., "Neutralization of Recombinant Hirudin: Some Practical Considerations", Seminars in Thrombosis and Homeostasis, vol. 17, No. 2, 137-144 (1991).
Fareed et al., "Some Objective Consideration for the Neutralization of the Anticoagulant Actions of Recombinant Hirudin", Haemestasis, vol. 21 (suppl. 1), 64-72 (1991).
Irani et al., "Reversal of Hirudin-Induced Bleeding Diathesis by Prothrombin Complex Concentrate", The American Journal of Cardiology, vol. 75, 422-423 (1995).
"Parenteral Preparations", Remington's Pharmaceutical Sciences, 15th Edition, Easton: Mack Publishing Co., pp. 1461-1487 (1975).
"Isotonic Solutions", Remington's Pharmaceutical Sciences, 15th Edition, Easton: Mack Publishing Co., pp. 1405-1412 (1975).
Wessler et al., "Biologic assay of a thrombosis-inducing activity in human serum", J. Appl. Physiol., vol. 14, No. 6, 943-946 (1959).
Hedner et al., "Recombinant Activated Factor VII in thr Treatment of Bleeding Episodes in Patients With Inherited and Acquired Bleeding Disorders", Transfusion Medicine Reviews, vol. 7, No. 2, 78-83 (1993).

Affiliated with

Also associated with

Rating

Pharmaceutical preparation for treating blood coagulation disord does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical preparation for treating blood coagulation disord, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparation for treating blood coagulation disord will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1114572